Feature Image

MMJ Business Daily: Firm to Research Cannabis Treatments Under NIH Deal

Posted on

Kannalife Sciences was mentioned in an article by MMJ Business Daily about their new licensing deal with the NIH.

A pharmaceutical company has inked a licensing agreement with the National Institutes of Health (NIH) to develop, test and possibly sell cannabis-based drugs for use in treating head trauma.”

Under the agreement, Kannalife Sciences will research CBD and other cannabis-derived treatments for chronic traumatic encephalopathy (CTE), a degenerative brain condition most common among athletes who played contact sports.

View full size PDF in new window

View Original Article